Immune thrombocytopenia

Common Name(s)

Immune thrombocytopenia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Immune thrombocytopenia" returned 368 free, full-text research articles on human participants. First 3 results:

Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
 

Author(s): Clémentine Estève, Maxime Samson, Alexandre Guilhem, Barbara Nicolas, Vanessa Leguy-Seguin, Sabine Berthier, Bernard Bonnotte, Sylvain Audia

Journal:

 

Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety ...

Last Updated: 31 Dec 1969

Go To URL
[Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis].
 

Author(s): Wei Qin, Shao-Ling Huang, Ting-Ting Li

Journal: Zhongguo Dang Dai Er Ke Za Zhi. 2017 Oct;19(10):1070-1076.

 

To investigate the clinical effect and safety of anti-D immunoglobulin (anti-D) in the treatment of children with newly diagnosed acute immune thrombocytopenia (ITP) through a Meta analysis.

Last Updated: 31 Dec 1969

Go To URL
Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia.
 

Author(s): J Zhou, Y Zhou, J Wen, X Sun, X Zhang

Journal:

 

Immune thrombocytopenia (ITP) is a disease characterized by isolated thrombocytopenia. Abnormal effector T cell activation is an important mechanism in the pathogenesis of ITP. Regulatory T cells (Treg) have a strong immunosuppressive function for T cell activation and their importance ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Immune thrombocytopenia" returned 58 free, full-text review articles on human participants. First 3 results:

Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.
 

Author(s): David Buchbinder, Diane Nugent, Loan Hsieh

Journal:

 

Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. In approximately one-third of cases, the duration of thrombocytopenia will extend beyond 12 months consistent with a diagnosis of chronic ITP. Minor bleeding manifestations ...

Last Updated: 31 Dec 1969

Go To URL
A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review.
 

Author(s): Xiaowei Hong, Xiaoqian Wang, Zhiyong Wang

Journal:

 

Acyclovir has been widely used to treat infections caused by herpes simplex virus (HSV) and varicella zoster virus (VZV). The common adverse effects of this drug include nausea, diarrhea, headache, dizziness and mental changes. The immune thrombocytopenia induced by acyclovir is rare.

Last Updated: 31 Dec 1969

Go To URL
Current Management of Primary Immune Thrombocytopenia.
 

Author(s): Drew Provan, Adrian C Newland

Journal: Adv Ther. 2015 Oct;32(10):875-87.

 

Primary immune thrombocytopenia is an autoimmune disorder of unknown cause affecting both children and adults. The low peripheral blood platelet count is caused by premature platelet destruction by self-reacting antibodies in addition to an impairment of platelet production. The disease ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
 

Status: Not yet recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 5 Jan 2017

Go to URL
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 26 Oct 2017

Go to URL
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 24 Jan 2017

Go to URL